Ten year trends in cardiac implantable electronic devices in New Zealand: a national data linkage study (ANZACS-QI 51).

Foo, Fang Shawn; Stiles, Martin K.; Lee, Mildred; Looi, Khang‐Li; Clare, Geoffrey C.; Webber, Matthew; Boddington, Dean; Jackson, Rod; Poppe, Katrina; Kerr, Andrew

doi:10.22541/au.159248746.64849861

Cited by 4 publications

(8 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The PPM implant rates in New Zealand increased at an average of 4.1% per year compared with 2.3% per year in Australia and 2.7% per year in the United Kingdom over the past decade. 1,28 The ICD implant rate (for new and replacement procedures) in New Zealand for 2016 was 141.9/ million, 6 Over the recent decade, the ICD implant rates in New Zealand increased at an average of 4.4% per year compared with 13.3% per year and 16.7% per year in the United Kingdom and Australia respectively. 1,28 The United States had an increase of 3.6% per year between 2011 and 2014.…”

Section: Comparisons With International Implant Rates and Trendsmentioning

confidence: 99%

“…[2][3][4][5] The CIED implant rates in New Zealand have increased significantly over the past decade, but regional trends in implant rates are unclear. 6 This paper aims to provide a trend analysis of new CIED implant by region and district health board (DHB) over the past decade.…”

Section: Introductionmentioning

confidence: 99%

“…PPM are generally indicated for the management of bradyarrhythmias, while ICD are generally used for the primary and secondary prevention of sudden cardiac death in patients at high risk of ventricular arrhythmias 2–5 . The CIED implant rates in New Zealand have increased significantly over the past decade, but regional trends in implant rates are unclear 6 . This paper aims to provide a trend analysis of new CIED implant by region and district health board (DHB) over the past decade.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Regional variation in cardiac implantable electronic device implants trends in New Zealand over the past decade (ANZACS‐QI 54)

Foo

Poppe

Lee

et al. 2022

Internal Medicine Journal

Self Cite

View full text Add to dashboard Cite

Background Permanent pacemaker (PPM) and implantable cardioverter defibrillator (ICD) implant rates have increased in New Zealand over the past decade. Aims To provide a contemporary analysis of regional variation in implant rates. Methods New PPM and ICD implants in patients aged ≥15 years were identified for 10 years (2009–2018) using procedure coding in the National Minimum Datasets, which collects all New Zealand public hospital admissions. Age‐standardised new implant rates per million adult population were calculated for each of the four regions (Northern, Midland, Central and Southern) and the 20 district health boards (DHB) across those regions. Trend analysis was performed using joinpoint regression. Results New PPM implant rates increased nationally by 3.4%/year (P < 0.001). The Northern region had the highest new PPM implant rate, increasing by 4.5%/year (P < 0.001). Excluding DHB with <50 000 people, the new PPM implant rate for 2017/2018 was highest in Counties Manukau DHB (854.3/million; 95% confidence interval (CI): 774.9–933.6/million) and lowest in Canterbury DHB (488.6/million; 95% CI: 438.1–539.0/million). New ICD implant rates increased nationally by 3.0%/year (P = 0.002). The Midland region had the highest new ICD implant rate, increasing by 3.8%/year (P = 0.013). Excluding DHB with <50 000 people, the new ICD implant rate for 2017−2018 was highest in the Bay of Plenty DHB (228.5/million; 95% CI: 180.4–276.6/million) and lowest in Canterbury DHB (90.2/million; 95% CI: 69.9–110.4/million). Conclusion There was significant variation in PPM and ICD implant rates across regions and DHB, suggesting potential inequity in patient access across New Zealand.

show abstract

Section: Comparisons With International Implant Rates and Trendsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Regional variation in cardiac implantable electronic device implants trends in New Zealand over the past decade (ANZACS‐QI 54)

Foo

Poppe

Lee

et al. 2022

Internal Medicine Journal

Self Cite

View full text Add to dashboard Cite

show abstract

“…Over the last decades, the number of cardiac implantable electronic devices (CIED) implanted has steadily increased as technological advances have allowed for a greater number of conditions to be treated with CIEDs 1,2 . Long‐term CIED implants are often associated with a need to add or replace existing electrodes due to lead failure or need for device upgrade, which in many cases results in lead abandonment, possibly increasing the risk of venous thrombosis 3–5 and complicating future lead extraction procedures 6,7 .…”

Section: Introductionmentioning

confidence: 99%

Current practice in transvenous lead extraction in Latin America: Latin American Heart Rhythm Association survey

Díaz¹,

Romero

Costa

et al. 2021

Cardiovasc electrophysiol

View full text Add to dashboard Cite

Background Transvenous lead extraction (TLE) is standard of care for the management of patients with cardiac implantable electronic device infection or lead‐related complications. Currently, objective data on TLE in Latin America is lacking. Objective To describe the current practice standards in Latin American centers performing TLE. Methods An online survey was sent through the mailing list of the Latin American Heart Rhythm Society. Online reminders were sent through the mailing list; duplicate answers were discarded. The survey was available for 1 month, after which no more answers were accepted. Results A total of 48 answers were received, from 44 different institutions (39.6% from Colombia, 27.1% from Brazil), with most respondents (82%) being electrophysiologists. Twenty‐nine institutions (66%) performed <10 lead extractions/year, with 7 (16%) institutions not performing lead extraction. Although most institutions in which lead extraction is performed reported using several tools, mechanical rotating sheaths were cited as the main tool (66%) and only 13% reported the use of laser sheaths. Management of infected leads was performed according to current guidelines. Conclusion This survey is the first attempt to provide information on TLE procedures in Latin America and could provide useful information for future prospective registries. According to our results, the number of centers performing high volume lead extraction in Latin America is smaller than that reported in other continents, with most interventions performed using mechanical tools. Future prospective registries assessing acute and long‐term success are needed.

show abstract

“…Over the last decades, the number of cardiac implantable electronic devices (CIED) implanted has steadily increased as technological advances have allowed for a greater number of conditions to be treated with CIEDs (1,2). Long-term CIED implants are usually associated with a need to add or replace existing electrodes due to lead failure or need for device upgrade, with many patients having abandoned leads which increase the risk of infection and venous thrombosis.…”

Section: Introductionmentioning

confidence: 99%

Current practice in Transvenous Lead Extraction in Latin-American: Latin-American Heart Rhythm Association Survey

Díaz¹,

Romero

Costa

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: Transvenous lead extraction (TLE) is standard of care for the management of patients with cardiac implantable electronic device infection or lead related complications. Currently, objective data on TLE in Latin America is lacking. Objective: To describe the current practice standards in Latin American centers performing TLE. Methods: An online survey was sent through the mailing list of the Latin American Heart Rhythm Association (LAHRS). Online reminders were sent through the mailing list; duplicate answers were discarded. The survey was available for one month, after which no more answers were accepted. Results: A total of 48 answers were received, from 44 different institutions (39.6% from Colombia, 27,1% from Brazil), with most respondents (83%) being electrophysiologists. Twenty-nine institutions (66%) performed less than 10 lead extractions/year, with 7 (15%) institutions not performing lead extraction. Although most institutions in which lead extraction is performed reported using several tools, mechanical rotating sheaths were cited as the main tool (73%), 13.5% reported the use of mechanical extraction sheaths and only 13.5% reporting the use of laser sheaths. Management of infected leads was performed according to current guidelines. Conclusion: This survey is the first attempt to provide information on TLE procedures in Latin America and could provide useful information for future prospective registries. According to our results, the number of centers performing high volume lead extraction in Latin America is smaller than that reported in other continents, with most interventions performed using mechanical tools. Future prospective registries assessing acute and long-term success are needed.

show abstract

Ten year trends in cardiac implantable electronic devices in New Zealand: a national data linkage study (ANZACS-QI 51).

Cited by 4 publications

References 35 publications

Regional variation in cardiac implantable electronic device implants trends in New Zealand over the past decade (ANZACS‐QI 54)

Regional variation in cardiac implantable electronic device implants trends in New Zealand over the past decade (ANZACS‐QI 54)

Current practice in transvenous lead extraction in Latin America: Latin American Heart Rhythm Association survey

Current practice in Transvenous Lead Extraction in Latin-American: Latin-American Heart Rhythm Association Survey

Contact Info

Product

Resources

About